Back to results
CompletedPhase 2

Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT00030537

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Center for Cancer Research

Bethesda, Maryland, United States

+1 additional location

View on ClinicalTrials.gov
Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer — TrialFind